Evgen Pharma PLC (AIM:EVG) CEO Dr Huw Jones and new CFO Toni Hanninen speak to Thomas Warner from Proactive after the clinical stage drug development company announced its interim results for the six months to 31 September 2023.

Dr Jones gives an overview of how Evgen has been performing on the operational side, highlighting clinical progress, the successful receipt of some new grant funding as well as changes to the board and to the executive team with the hiring of Toni Hanninen in late summer.

Hanninen gives an overview of how Evgen performed financial during the reporting period, noting that there were no nasty surprises during the six months and that the company's cash runway of £3.7mln currently runs to the end of 2024. He goes on to say that he is "very very delighted" with the length of the runway given the financial challenges many of Evgen's peers are currently facing.

#ProactiveInvestors #EVG #Evgen

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Bloomsbury Publishing PLC (LSE:BMY) founder and chief executive Nigel Newton CBE speaks to Thomas Warner from Proactive after the leading independent publishing house published its interim results for the six months to 31 August 2023.

Newton starts by saying that the team is "thrilled to have its fourth consecutive double-digit growth performance in both sales and profits" for one of its first halves, adding that the decision to branch out into academic publishing has given the company an almost uniquely well-balanced calendar that protects from the more typical heavy weighting of sales toward the Christmas season.

He goes on to explain more about how Bloomsbury has been delivering organic growth, highlighting the strong performance of its fantasy offering and hinting at further investment in the genre as well as in science fiction.

The company announced in its interim statement that it currently holds around £39.1mln in cash, and Newton says that having already completed more than 30 acquisitions Bloomsbury remains on the lookout for fresh opportunities.

#ProactiveInvestors #publishing #BMY

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Base Resources Limited (AIM:BSE, ASX:BSE) CFO Kevin Balloch talks Proactive through the company’s September quarter highlights. Prices for ilmenite and rutile improved during the period while zircon prices softened on sluggish demand. Meanwhile, mining at the Kwale operations in Kenya will end in December 2024 with processing to stop shortly thereafter due to limited tailings storage capacity. Activity at Kwale will now turn to detailed closure planning and transition to post-mining land use and progression of its Toliara Project in Madagascar.

#ProactiveInvestors #ASX #BSE #ilmenite #rutile

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

NickelSearch Ltd (ASX:NIS) MD Nicole Duncan tells Proactive a regional exploration program — including detailed mapping, rock chip sampling and infill soil sampling — has identified 28 new areas of interest for lithium mineralisation at the Carlingup Project in Western Australia. An independent review of geochemistry samples at Carlingup also aided the company in identifying areas of interest specifically for lithium-caesium-tantalum (LCT) style pegmatites.

#ProactiveInvestors #ASX #NIS #lithium

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

OD6 Metals Ltd (ASX:OD6) MD Brett Hazelden gives Proactive a recap on the company’s September quarter highlights and its recent phase 3 drilling. This included a maiden inferred mineral resource estimate of 344 million tonnes at 1,308ppm total rare earth oxides (TREO) for its Splinter Rock rare earth project, which is emerging as one of the largest and highest-grade clay-hosted rare earth resources in Australia. OD6 recently released "outstanding" results with grades up to 4,159 ppm TREO from phase 3 drilling with further assays and metallurgical results due in November.

#ProactiveInvestors #ASX #OD6 #RareEarths

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Anteris Technologies Ltd (ASX:AVR, OTC:AMEUF) CEO Wayne Paterson speaks with Proactive after the successful completion of enrolment for the company’s early feasibility study (EFS) to evaluate DurAVR™ THV. This unique device represents a new class of biomimetic valve and stands as the world's only balloon-expandable, single-piece transcatheter aortic valve. The study aims to assess the safety and feasibility of DurAVR™ THV in treating 15 patients suffering from symptomatic, severe native aortic stenosis, and is critical to obtaining US Food and Drug Administration clearance.

#ProactiveAustralia #ASX #AVR #biomimeticvalve

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Tempest Minerals Ltd (ASX:TEM) managing director Don Smith discusses with Proactive the promising geochemical findings from surface sampling at the the Yalgoo projects' Sanity target. The results reveal zones of significant anomalism for gold and other metals and pave the way for further exploration and possible drilling in the area. Peak rock chip values reached 7 grams per tonne of gold, 0.2% copper, and over 60% iron within broader envelopes of anomalous soil geochemistry.

#ProactiveAustralia #ASX #TEM

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

BioHarvest Sciences CEO Ilan Sobel joined Steve Darling from Proactive to share Ilan Sobel, the CEO of BioHarvest Sciences, recently shared some exciting developments in an interview with Steve Darling from Proactive. The company has achieved a major milestone by successfully closing the first tranche of their financing, raising nearly $12 million, even in the face of challenging market conditions. This accomplishment underscores the significant investor confidence in BioHarvest's strategic vision and the strength of its management team.

The capital raised through this financing round will play a pivotal role in advancing several key initiatives within BioHarvest Sciences. One of the notable areas of focus is new product development and expansion. BioHarvest has ambitious plans to expand its product range, moving from a single SKU to ten SKUs spanning across five different categories. Leveraging their advanced scientific capabilities, proven efficacy, and exceptional taste, the company is poised to make a significant impact in these markets. The eagerly awaited flagship product, a revolutionary coffee offering, is slated to disrupt the market starting in December.

Geographical expansion is another crucial aspect of BioHarvest's growth strategy. With recent approval from Health Canada, the company is gearing up to enter the Canadian market, further extending its global footprint.

Additionally, BioHarvest is accelerating clinical trials across various domains, positioning itself for substantial growth over the next 12 to 24 months. These clinical trials will not only underscore the efficacy of their products but also enhance their credibility and market presence.

Despite the challenges posed by the current market conditions, BioHarvest remains unwavering in its commitment to the safety of its employees and the consistent delivery of high-quality products. The company's focus for the remainder of 2023 includes robust marketing initiatives and the highly anticipated launch of their innovative coffee product, aimed at revitalizing the stagnant decaffeinated coffee market.

#proactivinvestors #cse #bhsc #otcqb #cnvcf #pharma #biotech #hearthealth #investing

#IlanSobel #FundingSuccess #CoffeeLaunch #InvestmentNews #InnovationUpdate #BusinessGrowth #ProductExpansion #HealthCanadaApproval #ClinicalTrials #MarketDisruption #BioTech #CEOInsights #ProductDevelopment #GeographicalExpansion #Efficacy #TasteExperience #InvestorConfidence #MarketStrategy #FutureGrowth #Resilience #SafetyFirst #IsraeliBusiness #SubscriptionModel #CoffeeRevolution #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Baselode Energy CEO James Sykes joined Steve Darling from Proactive to share some exciting developments related to the ACKIO uranium prospect on the Hook project, where the company has been conducting a significant diamond drilling program.

Sykes reported on the results of assays from five drill holes out of the total 25 holes drilled in the extensive 7,512-meter program. These results reveal that uranium mineralization, alteration, and structural features all continue to persist at depth, with no indications of diminishing. This is a promising sign of the mineral potential in the area.

One particularly significant discovery from the drill program is the identification of new mineralization in Pod 4, which was found at a substantial depth and remains open. This discovery marks a high-priority drill target for follow-up exploration in 2024, highlighting the ongoing potential for further resource expansion and development.

Additionally, the results from drill hole AK23-92 suggest that Pods 4 and 7 are situated along the same east-dipping geological structure. This structure extends from the overburden contact, beginning approximately 30 meters below the surface and continuing to remain open at depths exceeding 200 meters. This finding provides valuable insights into the geological continuity of mineralization at the ACKIO uranium prospect.

Baselode Energy is well-positioned to continue its exploration efforts in this promising region. The company is fully funded, with plans for an aggressive exploration program in 2024. This follows the successful completion of a $10.7 million financing, which will enable Baselode Energy to further advance its efforts in uncovering and developing valuable uranium resources.

#proactiveinvestors #baselodeenergycorp #tsxv #find #otcqb #bsenf #mining #uranium

#MiningIndustry #Exploration #Mineralization #HookProject #CEOInterview #ResourceExploration #Geology #MineralDiscovery #Investment #ExplorationBudget #MineralizationPods #GeologicalResults #ResourceSector #DrillingProgram #DepthPotential #MineralizationZones #MiningUpdates #NaturalResources #InvestorUpdate #ResourceInvestment #EnergyCorp #MineralDeposits #MineralExploration #ResourceDiscovery#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Rock Tech Lithium Inc CEO Dirk Harbecke speaks to Thomas Warner from Proactive after the integrated lithium company announced plans to raise around C$10mln via a non-brokered private placement.

Harbecke starts by giving a brief overview of the business, which currently has operations in both Canada and Germany.

Around half of the money raised by the private placement will be used to finance continued exploration and development at the company’s Georgia Lake Lithium Project in Ontario, Canada.

Harbecke explains that the firm is developing a lithium hydroxide converter in Eastern Germany, adding that the hard work done recently will ultimately enable Rock Tech to construct similar plants in Canada and elsewhere.

Touching on the recent fundraise, Harbecke expresses confidence in future growth in demand for lithium and says Rock Tech is particularly well-placed to contribute to the creation of the necessary new supply chains – not least because of the expertise it has developed in converter technology.

#ProactiveInvestors #lithium #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews